Sheeja Aravindan

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Cancer Stem Cells

Internal Carotid Artery

Top Venues

Journal of cancer metastasis and treatment

Cell biology and toxicology

Expert opinion on therapeutic targets

This page only lists publications with an associated author ORCID identifier.

Publications

Natarajan Aravindan, Mohan Natarajan, Dinesh Babu Somasundaram, Sheeja Aravindan
Chemoprevention of neuroblastoma: progress and promise beyond uncertainties. Journal of cancer metastasis and treatment 9 (2023)
Natarajan Aravindan, Mohan Natarajan, Dinesh Babu Somasundaram, Sheeja Aravindan
Chemoprevention of neuroblastoma: progress and promise beyond uncertainties. Journal of cancer metastasis and treatment 9 (2023)
Natarajan Aravindan, Mohan Natarajan, Dinesh Babu Somasundaram, Sheeja Aravindan
Chemoprevention of neuroblastoma: progress and promise beyond uncertainties. Journal of cancer metastasis and treatment 9 (2023)
Natarajan Aravindan, Mohan Natarajan, Dinesh Babu Somasundaram, Sheeja Aravindan
Chemoprevention of neuroblastoma: progress and promise beyond uncertainties. Journal of cancer metastasis and treatment 9 (2023)
Natarajan Aravindan, Mohan Natarajan, Dinesh Babu Somasundaram, Sheeja Aravindan
Chemoprevention of neuroblastoma: progress and promise beyond uncertainties. Journal of cancer metastasis and treatment 9 (2023)
Drishti Jain, Dinesh Babu Somasundaram, Sheeja Aravindan, Zhongxin Yu, Ashley A Baker, Azadeh Esmaeili, Natarajan Aravindan
Prognostic significance of NT5E/CD73 in neuroblastoma and its function in CSC stemness maintenance. Cell biology and toxicology (2021)
Natarajan Aravindan, Dinesh Babu Somasundaram, Terence S Herman, Sheeja Aravindan
Significance of hematopoietic surface antigen CD34 in neuroblastoma prognosis and the genetic landscape of CD34-expressing neuroblastoma CSCs. Cell biology and toxicology 37 (3) (2020)
Natarajan Aravindan, Terence S Herman, Sheeja Aravindan
Emerging therapeutic targets for neuroblastoma. Expert opinion on therapeutic targets 24 (9) (2020)